Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Autoimmune and autoinflammatory diseases involve immune dysregulation and inflammation.
• Effective targeted therapies are limited.
• Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2) is an endogenous regulator of inflammation, primarily in myeloid cells.

Purpose of the Study:

• To review the structure, expression, and functions of PSTPIP2.
• To explore PSTPIP2's role in inflammatory signaling and immune cell behavior.
• To highlight PSTPIP2's potential as a therapeutic target for inflammatory diseases.

Main Methods:

• Literature review of PSTPIP2's molecular and cellular functions.
• Analysis of PSTPIP2's involvement in disease mechanisms.
• Examination of data from PSTPIP2-deficient models.

Main Results:

• PSTPIP2 regulates IL-1β maturation, NF-κB and ERK signaling, macrophage polarization, and osteoclast activity.
• PSTPIP2 is implicated in chronic multifocal osteomyelitis, rheumatoid arthritis, SAPHO syndrome, and bullous pemphigoid.
• PSTPIP2 deficiency models offer mechanistic and translational insights.

Conclusions:

• PSTPIP2 is a critical immunoregulatory node linking cytoskeletal organization to inflammatory control.
• Further research into PSTPIP2 functions may lead to precision therapies for autoimmune and autoinflammatory diseases.
• PSTPIP2 shows potential as a biomarker and therapeutic target.